PL391552A1 - Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas - Google Patents

Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas

Info

Publication number
PL391552A1
PL391552A1 PL391552A PL39155210A PL391552A1 PL 391552 A1 PL391552 A1 PL 391552A1 PL 391552 A PL391552 A PL 391552A PL 39155210 A PL39155210 A PL 39155210A PL 391552 A1 PL391552 A1 PL 391552A1
Authority
PL
Poland
Prior art keywords
strains
stenotrophomonas
bacteriophages
drug
bacterial infections
Prior art date
Application number
PL391552A
Other languages
English (en)
Other versions
PL212258B1 (pl
Inventor
Beata Weber-Dąbrowska
Andrzej Górski
Marzena Łusiak-Szelachowska
Maciej Żaczek
Original Assignee
Instytut Immunologii i Terapii Doświadczalnej PAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Immunologii i Terapii Doświadczalnej PAN filed Critical Instytut Immunologii i Terapii Doświadczalnej PAN
Priority to PL391552A priority Critical patent/PL212258B1/pl
Priority to CN2011800336765A priority patent/CN103096906A/zh
Priority to US13/805,408 priority patent/US20140193882A1/en
Priority to EP11744114.7A priority patent/EP2582378A1/en
Priority to PCT/PL2011/050025 priority patent/WO2011162626A1/en
Publication of PL391552A1 publication Critical patent/PL391552A1/pl
Publication of PL212258B1 publication Critical patent/PL212258B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL391552A 2010-06-20 2010-06-20 Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas PL212258B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL391552A PL212258B1 (pl) 2010-06-20 2010-06-20 Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas
CN2011800336765A CN103096906A (zh) 2010-06-20 2011-06-20 用于治疗细菌感染，特别是由寡养单胞菌属的抗药性细菌株系引起的细菌感染的新颖细菌噬菌体株系
US13/805,408 US20140193882A1 (en) 2010-06-20 2011-06-20 Novel strains of bacteriophages for the treatment of bacterial infections, particularly by strains of drug-resistant bacteria of the genus stenotrophomonas
EP11744114.7A EP2582378A1 (en) 2010-06-20 2011-06-20 Novel strains of bacteriophages for the treatment of bacterial infections, particularly by strains of drug-resistant bacteria of the genus stenotrophomonas
PCT/PL2011/050025 WO2011162626A1 (en) 2010-06-20 2011-06-20 Novel strains of bacteriophages for the treatment of bacterial infections, particularly by strains of drug-resistant bacteria of the genus stenotrophomonas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL391552A PL212258B1 (pl) 2010-06-20 2010-06-20 Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas

Publications (2)

Publication Number Publication Date
PL391552A1 true PL391552A1 (pl) 2012-01-02
PL212258B1 PL212258B1 (pl) 2012-09-28

Family

ID=44509561

Family Applications (1)

Application Number Title Priority Date Filing Date
PL391552A PL212258B1 (pl) 2010-06-20 2010-06-20 Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas

Country Status (5)

Country Link
US (1) US20140193882A1 (pl)
EP (1) EP2582378A1 (pl)
CN (1) CN103096906A (pl)
PL (1) PL212258B1 (pl)
WO (1) WO2011162626A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017016602A1 (en) * 2015-07-29 2017-02-02 Curetis Gmbh Genetic testing for predicting resistance of stenotrophomonas species against antimicrobial agents

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB829266A (en) 1957-03-20 1960-03-02 Biogena A method of manufacturing bacteriophages in solid dry form
SU543260A1 (ru) 1975-07-25 1984-04-15 Всесоюзный Ордена Трудового Красного Знамени Научно-Исследовательский Противочумный Институт "Микроб" Способ получени холерных бактериофагов дл дифференциации вибрионов Эль-Тор на вирулентные и авирулентные
CS192212B1 (en) 1977-04-22 1979-08-31 Miloslav Mazacek Method of producing dry form bacteriophages
EP0290295B1 (en) 1987-05-07 1992-08-05 Microbial Developments Limited Antimicrobial preparations
WO1990003122A1 (en) 1988-09-26 1990-04-05 Microbial Developments Limited Antimicrobial preparations
GB8918983D0 (en) 1989-08-21 1989-10-04 Unilever Plc Composition for hygiene purposes
DE4005874A1 (de) 1990-02-24 1991-11-07 Boehringer Mannheim Gmbh Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine
GB2253859A (en) 1991-02-28 1992-09-23 Microbial Dev Ltd Use of bacteriophages to prevent microbial infestation
GB2255561B (en) 1991-04-20 1995-06-21 Agricultural & Food Res Lysins from bacteriophages
WO1995005454A1 (en) 1992-02-22 1995-02-23 Cambridge Bacteriophage Technologies Ltd. Engineered bacteriophages and vaccines containing them
GB9220027D0 (en) 1992-09-22 1992-11-04 Mini Agriculture & Fisheries Method and kits for detection of bacteria
WO1996007329A1 (en) 1994-09-09 1996-03-14 University Of Maryland Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases
GB9500851D0 (en) 1995-01-17 1995-03-08 Bionvent International Ab Method of selecting specific bacteriophages
DE19517940A1 (de) 1995-05-18 1996-11-21 Merck Patent Gmbh Nachweis von Listerien mittels rekombinanter Bakteriophagen
WO1998008944A1 (fr) 1996-08-26 1998-03-05 Bio Venture Bank Co., Ltd. Nouveau bacteriophage et procede de criblage associe, nouvelles matieres biobactericides preparees avec ledit bacteriophage et reactif utilise pour detecter celui-ci
RU2109055C1 (ru) 1996-11-27 1998-04-20 Дочернее предприятие "Биофаг" Научно-производственного объединения "Иммунопрепарат" Способ выделения бактериофагов
AU5423400A (en) 1999-06-25 2001-01-31 Spring Diagnostics Ltd. Bacteriophage library useful for typing bacteria and system and method utilizingsame
ES2256028T3 (es) 1999-07-30 2006-07-16 Profos Ag Deteccion e identificacion de cepas bacterianas.
CA2684311A1 (en) * 2007-04-18 2008-10-30 Cornell University Microorganism detection method and apparatus

Also Published As

Publication number Publication date
US20140193882A1 (en) 2014-07-10
WO2011162626A1 (en) 2011-12-29
EP2582378A1 (en) 2013-04-24
PL212258B1 (pl) 2012-09-28
CN103096906A (zh) 2013-05-08

Similar Documents

Publication Publication Date Title
AP3269A (en) Methods and compounds for treating paramyxoviridaevirus infections
LT2732023T (lt) Bakterijų kamienai, išskirti iš kiaulių
ZA201301598B (en) Benzoxaborole derivatives for treating bacterial infections
ZA201404078B (en) Bradyrhizobium strains
HK1198689A1 (en) Antibody formulations and methods
EP2523944A4 (en) COMPOUNDS AND COMPOSITIONS FOR IMPROVING COGNITION, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT
PL2696890T3 (pl) Leczenie infekcji drobnoustrojowych
IL220523A0 (en) New process for the preparation of dronedarone
EP2582626A4 (en) UZM-35 ZEOLITHIC COMPOSITION, METHOD FOR PRODUCING THE SAME, AND METHODS
HUE051761T2 (hu) Testreszabott liposzómák bakteriális fertõzések kezelésére
SI3616695T1 (sl) Ceftolozan/tazobaktam za zdravljenje intrapulmonalnih okužb
PL2640711T3 (pl) Ulepszony sposób otrzymywania rufinamidu
EP2564835A4 (en) FAST DISSOLVING SOLID PHARMACEUTICAL FORM FOR THE TREATMENT OF BACTERIAL INFECTIONS
PL391552A1 (pl) Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas
PL392681A1 (pl) Nowe szczepy bakteriofagów do leczenia zakażeń bakteryjnych, zwłaszcza szczepami bakterii lekoopornych z rodzaju Klebsiella
PL391551A1 (pl) Sposób otrzymywania bakteriofagów
GB201117072D0 (en) Use of non e.164 msisdns
WO2013006854A9 (en) Compositions and methods for treating enterobacteriaceae
WO2013013238A3 (en) Compounds and related compositions and methods of use
ZA201308806B (en) Liposomal vancomycin for the treatment of mrsa infections
WO2013013240A3 (en) Macrocyclic compounds and related compositons and methods of use
AU2012902243A0 (en) Method of treating Seedosporium spp. infection
PL391328A1 (pl) Sposób uzyskiwania oczyszczonych preparatów bakteriofagowych
EP2670407A4 (en) TREATMENT OF BACTERIAL INFECTIONS
AU2010901718A0 (en) Eczema treatment